Skip to content

The Effect of Self-Acupressure on Blood Pressure, Stress, and Well-Being Levels in Individuals With Hypertension

The Effect of Self-Acupressure on Blood Pressure, Stress, and Well-Being Levels in Individuals With Hypertension: A Three-Arm Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07577973
Acronym
SAPH
Enrollment
72
Registered
2026-05-11
Start date
2026-06-01
Completion date
2026-10-01
Last updated
2026-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PRIMARY HYPERTENSION

Keywords

Acupressure Hypertension Self-care Nursing Stress Well-being Randomized Controlled Trial

Brief summary

This randomized controlled trial examines the effects of nurse-led self-acupressure at HT7, LI4, PC6, and EX3 points on blood pressure, stress, and well-being in adults with primary hypertension. Participants are randomized to real acupressure, sham acupressure, or usual care groups for 2 weeks.

Interventions

BEHAVIORALReal Acupressure

Acupressure applied to HT7 (Shenmen), LI4 (Hegu), PC6 (Neiguan) bilaterally, and EX3 (Yintang). Pressure applied for 15 seconds per point, 3 days per week for 2 weeks by trained researcher. Total session duration approximately 1 minute.

light pressure applied to non-acupoint sites 1-1.5 cm from HT7İLI4,PC6 and EX3 points for 15 seconds per site,3 days per week for 2 weeks

OTHERUsual Care

Standard hypertension management including prescribed antihypertensive medication and routine clinical nursing follow-up for 2 weeks. No acupressure applied.

Sponsors

Abant Izzet Baysal University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Intervention model description

Participants will be randomized into 3 groups:real acupressure, sham acupressure, and usual care

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Aged 18-65 years 2. Diagnosed with primary hypertension (Stage 1 or 2) 3. Systolic blood pressure 130-179 mmHg or diastolic 80-109 mmHg 4. Taking antihypertensive medication 5. Able to understand and communicate in Turkish 6. Willing to provide written informed consent

Exclusion criteria

1. Secondary hypertension 2. Pregnancy or lactation 3. Severe cardiovascular disease (heart failure, myocardial infarction within 6 months) 4. Stroke history within 6 months 5. Skin lesions or infection at acupressure sites (HT7, LI4, PC6, EX3) 6. Peripheral neuropathy affecting sensation 7. Current use of anticoagulant therapy 8. Participation in another clinical trial within 30 days

Design outcomes

Primary

MeasureTime frameDescription
change in blood pressurebaseline and week 2change from baseline in systolic and diastolic blood pressure measured using an automated office blood pressure monitor at 2 weeks

Secondary

MeasureTime frameDescription
change in perceived stressbaseline, week 2Change from baseline in Perceived Stress Scale-14 (PSS-14) total score at 2 weeks. Scores range from 0 to 56, with higher scores indicating greater perceived stress
change in mental well-beingbaseline, week 2Change from baseline in Warwick-Edinburgh Mental Well-being Scale (WEMWBS) total score at 2 weeks. Scores range from 14 to 70, with higher scores indicating better mental well-being

Countries

Turkey (Türkiye)

Contacts

CONTACTSeymanur Ozdemir Arslan, MSc,Phd Candidate
seymanurarslan@duzce.edu.tr+90 0380 523 7827
PRINCIPAL_INVESTIGATORSaadet Can Cicek, Associate Professor,PhD

Abant Izzet Baysal University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026